We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
-3.71%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$228M
AUM Growth
-$19.8M
Cap. Flow
-$16.2M
Cap. Flow %
-7.1%
Top 10 Hldgs %
56.44%
Holding
47
New
2
Increased
13
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$2.81M
2
FHI icon
Federated Hermes
FHI
+$1.75M
3
CNNE icon
Cannae Holdings
CNNE
+$1.73M
4
TFC icon
Truist Financial
TFC
+$1.7M
5
RF icon
Regions Financial
RF
+$970K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.62M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.14M
3
GS icon
Goldman Sachs
GS
+$878K
4
PRGO icon
Perrigo
PRGO
+$852K
5
SHEL icon
Shell
SHEL
+$286K

Sector Composition

Rank Sector Weight
1 Financials 25.24%
2 Healthcare 16.2%
3 Technology 4.15%
4 Consumer Discretionary 1.9%
5 Materials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$58.2M 25.57%
107,000
-3,000
-3% -$1.57M
PFE icon
2
CALL
Pfizer
PFE
$141B
$8.95M 3.93%
320,000
-60,000
-16% -$1.65M
UBER icon
3
Uber
UBER
$147B
$8.81M 3.87%
121,148
VTRS icon
4
Viatris
VTRS
$20B
$8.62M 3.79%
810,889
+254,700
+46% +$2.81M
EEM icon
5
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.2B
$7.96M 3.49%
186,800
-17,000
-8% -$713K
PFE icon
6
Pfizer
PFE
$141B
$7.92M 3.48%
283,192
-59,000
-17% -$1.62M
TFC icon
7
Truist Financial
TFC
$62.1B
$7.72M 3.39%
198,650
+45,000
+29% +$1.7M
WU icon
8
Western Union
WU
$2.7B
$7.21M 3.17%
590,140
+66,101
+13% +$859K
TEVA icon
9
Teva Pharmaceuticals
TEVA
$36.7B
$6.56M 2.88%
403,766
-74,000
-15% -$1.14M
COF icon
10
Capital One
COF
$128B
$6.55M 2.88%
47,310
FHI icon
11
Federated Hermes
FHI
$4.42B
$6.08M 2.67%
184,967
+52,057
+39% +$1.75M
WU icon
12
CALL
Western Union
WU
$2.7B
$5.94M 2.61%
486,000
+446,000
+1,115% +$5.79M
C icon
13
Citigroup
C
$217B
$5.49M 2.41%
86,434
WFC icon
14
Wells Fargo
WFC
$262B
$5.4M 2.37%
90,906
GILD icon
15
Gilead Sciences
GILD
$165B
$5.17M 2.27%
75,367
+11,464
+18% +$765K
VTRS icon
16
CALL
Viatris
VTRS
$20B
$4.88M 2.14%
459,000
-129,000
-22% -$1.43M
B
17
CALL
Barrick Mining
B
$58.7B
$4.5M 1.98%
270,000
-40,000
-13% -$679K
IVZ icon
18
CALL
Invesco
IVZ
$13.1B
$4.38M 1.92%
292,900
+48,700
+20% +$749K
CNNE icon
19
Cannae Holdings
CNNE
$640M
$4.33M 1.9%
238,594
+89,284
+60% +$1.73M
AMLP icon
20
Alerian MLP ETF
AMLP
$12.9B
$4.14M 1.82%
86,223
NTRS icon
21
Northern Trust
NTRS
$33.9B
$3.59M 1.58%
42,801
IVZ icon
22
Invesco
IVZ
$13.1B
$3.57M 1.57%
238,940
+30,840
+15% +$474K
XLE icon
23
State Street Energy Select Sector SPDR ETF
XLE
$38.5B
$3.55M 1.56%
78,000
-4,000
-5% -$186K
GILD icon
24
CALL
Gilead Sciences
GILD
$165B
$3.49M 1.53%
50,800
+28,800
+131% +$1.92M
PRGO icon
25
Perrigo
PRGO
$1.47B
$3.31M 1.45%
128,768
-29,000
-18% -$852K

Similar funds

Continental Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Continental Advisors held 47 positions worth $228M, down 8% from $248M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Continental Advisors withdrew a net $16.2M in Q2 2024, closing 4 positions and reducing 13 holdings. Its largest reduction was Pfizer, cutting an estimated $1.62M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Continental Advisors opened a new position in Dentsply Sirona worth $772K.

  • Continental Advisors's largest Q2 2024 buy was Dentsply Sirona: 31,000 shares worth $772K.
  • Continental Advisors added most to Viatris in Q2 2024, an estimated $2.81M increase.
  • Continental Advisors's biggest Q2 2024 reduction was Pfizer, cutting an estimated $1.62M.
  • Continental Advisors's ten largest holdings make up 56% of its $228M portfolio in Q2 2024.
  • Continental Advisors opened 2 new positions and closed 4 in Q2 2024.
  • Continental Advisors's portfolio value fell 8% quarter-over-quarter to $228M.

Based on Continental Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.